16 employees
Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
2019
$18M
from 2 investors over 2 rounds
Tavros Therapeutics raised $18M on October 12, 2022
Investors: Vividion Therapeutics. Inc.
Tavros Therapeutics raised $7.5M on September 27, 2022
Investors: KdT Ventures